Selecting Optimal Timing of Cranial Radiotherapy Based on the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) in Patients with NonSmall Cell Lung Cancer and Brain Metastases

被引：0
|
作者：
Zhai, X. [1 ]
Li, J. [1 ]
Jing, W. [2 ]
Jia, W. [1 ]
Zhu, H. [1 ]
Yu, J. [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[2] Shandong First Med Univ, Cent Hosp, Dept Oncol, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2145
引用
收藏
页码：E66 / E66
页数：1
相关论文
共 50 条
  • [1] Selecting optimal timing of cranial radiotherapy-based on the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) in patients with non-small cell lung cancer and brain metastases.
    Zhai, Xiaoyang
    Li, Ji
    Jing, Wang
    Jia, Wenxiao
    Zhu, Hui
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
    Carsten Nieder
    Mandy Hintz
    Oliver Oehlke
    Angelika Bilger
    Anca L. Grosu
    Radiation Oncology, 12
  • [3] Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
    Nieder, Carsten
    Hintz, Mandy
    Oehlke, Oliver
    Bilger, Angelika
    Grosu, Anca L.
    RADIATION ONCOLOGY, 2017, 12
  • [4] Estimating Survival in Patients With Lung Cancer and Brain Metastases An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
    Sperduto, Paul W.
    Yang, T. Jonathan
    Beal, Kathryn
    Pan, Hubert
    Brown, Paul D.
    Bangdiwala, Ananta
    Shanley, Ryan
    Yeh, Norman
    Gaspar, Laurie E.
    Braunstein, Steve
    Sneed, Penny
    Boyle, John
    Kirkpatrick, John P.
    Mak, Kimberley S.
    Shih, Helen A.
    Engelman, Alex
    Roberge, David
    Arvold, Nils D.
    Alexander, Brian
    Awad, Mark M.
    Contessa, Joseph
    Chiang, Veronica
    Hardie, John
    Ma, Daniel
    Lou, Emil
    Sperduto, William
    Mehta, Minesh P.
    JAMA ONCOLOGY, 2017, 3 (06) : 827 - 831
  • [5] IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)
    Sperduto, Paul
    Yang, T. Jonathan
    Beal, Kathryn
    Pan, Hubert
    Brown, Paul
    Bangdiwala, Ananta
    Shanley, Ryan
    Yeh, Norman
    Gaspar, Laurie E.
    Braunstein, Steve
    Sneed, Penny
    Boyle, John M.
    Kirkpatrick, John
    Mak, Kimberley
    Shih, Helen
    Engelman, Alex
    Roberge, David
    Arvold, Nils
    Alexander, Brian
    Awad, Mark
    Contessa, Joseph
    Chiang, Veronica
    Hardie, John
    Ma, Daniel
    Lou, Emil
    Sperduto, William
    Mehta, Minesh
    NEURO-ONCOLOGY, 2016, 18 : 27 - 27
  • [6] Estimating Survival in Patients with Non-small Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
    Jing, W.
    Li, J.
    Zhai, X.
    Jia, W.
    Hou, Y.
    Zhu, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E166 - E166
  • [7] External Validation of the Graded Prognostic Assessment for Patients with Non-Small Cell Lung Cancer and Brain Metastases Using Molecular Markers (Lung-molGPA)
    Hong, S. W.
    Jeon, W.
    Kim, J. S., Jr.
    Song, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E24 - E25
  • [8] Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
    Li, Ji
    Jing, Wang
    Zhai, Xiaoyang
    Jia, Wenxiao
    Zhu, Hui
    Yu, Jinming
    ONCOTARGETS AND THERAPY, 2021, 14 : 1623 - 1631
  • [9] Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases
    Wenxiao Jia
    Xiaoyang Zhai
    Xuquan Jing
    Qingdong Bao
    Shuhui Xu
    Hui Zhu
    Gang Wu
    Jinming Yu
    Journal of Neuro-Oncology, 2023, 164 (2) : 321 - 330
  • [10] Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases
    Jia, Wenxiao
    Zhai, Xiaoyang
    Jing, Xuquan
    Bao, Qingdong
    Xu, Shuhui
    Zhu, Hui
    Wu, Gang
    Yu, Jinming
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (02) : 321 - 330
12345